Roche says its planned purchase of cancer data specialist Flatiron Health Inc. will help the Swiss group progress its own pipeline while helping to design the use of real-world evidence to set new industry standards for oncology research and development.
The acquisition, announced Feb. 15, stems from an existing partnership between the two companies, with Roche already holding a 12.6%...